Lingli He
- Behavioral Neuroscience top 10%
- Endocrine and Autonomic Systems top 10%
- Neurology top 10%
-
- Hepatitis C virus research 5
-
- Hepatitis B Virus Studies 4
- Liver Disease Diagnosis and Treatment 3
-
- Acute Myeloid Leukemia Research 2
-
- Childhood Cancer Survivors' Quality of Life 2
-
- Drug Transport and Resistance Mechanisms 2
-
- Antibiotic Resistance in Bacteria 2
-
- Acute Lymphoblastic Leukemia research 2
Lingli He
24 papers receiving 587 citations
Peers
Comparison fields: 5 of 99
- Behavioral Neuroscience 63
- Biological Psychiatry 25
- Endocrine and Autonomic Systems 67
- Neurology 66
- Hepatology 38
Countries citing papers authored by Lingli He
This map shows the geographic impact of Lingli He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingli He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingli He more than expected).
Fields of papers citing papers by Lingli He
This network shows the impact of papers produced by Lingli He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingli He. The network helps show where Lingli He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lingli He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2021 | 15 | |
| 4 | 2020 | 21 | |
| 5 | 2019 | 6 | |
| 6 | 2018 | 23 | |
| 7 | 2017 | 110 | |
| 8 | 2017 | 1 | |
| 9 | 2016 | 6 | |
| 10 | 2013 | 19 | |
| 11 | [Clinical analysis and review of 8 cases with sinonasal neuroendocrine carcinoma]. | 2013 | 1 |
| 12 | [Association of interleukin 28B polymorphisms with response to pegylatedinterferon plus ribavirin therapy for chronic hepatitis C]. | 2012 | 1 |
| 13 | 2011 | 2 | |
| 14 | [Lamivudine-resistant analysis and management for chronic hepatitis B patients with initial lamivudine therapy]. | 2011 | 3 |
| 15 | 2009 | 31 | |
| 16 | 2007 | 54 | |
| 17 | 2004 | 52 | |
| 18 | 2003 | 18 | |
| 19 | 2003 | 63 | |
| 20 | 2002 | 114 |
About Lingli He
Lingli He is a scholar working on Hepatology, Aging and Physiology, having authored 24 papers that have together received 598 indexed citations. Recurring topics across this work include Hepatitis C virus research (5 papers), Hepatitis B Virus Studies (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Acute Myeloid Leukemia Research (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Behavioral Neuroscience (63 citations), Biological Psychiatry (25 citations) and Endocrine and Autonomic Systems (67 citations). Lingli He has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Ning Quan, Wenmin Lai, Randy J. Nelson, Staci D. Bilbo, Deborah L. Drazen, Bing Xu, San Ching, Manman Deng, Xuejun C. Zhang and Kai Chen. Their work appears in journals such as Cell Death and Disease, Pharmacogenomics, Proceedings of the Royal Society B Biological Sciences, Life Science Alliance and Protein Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.